Sponsor Pipeline

Jiangxi Kvvit Pharmaceutical Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
7
Active Trials
1
Recruiting
3
Phase 3
2
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-06 NCT07409922
Study of Single and Multiple Ascending Doses of KR23343 in Healthy Adult Participants
Recruitment opened
Active Trials by Phase
Phase 3
2
Phase 2/3
1
Phase 2
1
Phase 1
3
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07113392 A Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Suraxavir Marboxil for… Influenza Not Yet Recruiting
NCT07689539 Trial of DN022150 Versus Chemotherapy in Previously Treated Advanced Pancreatic Cancer… Pancreatic Cancer Not Yet Recruiting
Phase 2/3
NCT07656376 Clinical Trial of DN022150 Combined With AG Chemotherapy as First-line Treatment for… Pancreatic Cancer Not Yet Recruiting
Phase 2
NCT07345390 Safety, Efficacy and Pharmacokinetic Characteristics of KR230109 Cream in Facial Acne… Acne Vulgaris Not Yet Recruiting
Phase 1
NCT07409922 Study of Single and Multiple Ascending Doses of KR23343 in Healthy Adult Participants Healthy Recruiting
NCT07585383 A Phase I Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetic… Schizophrenia Not Yet Recruiting
NCT07618156 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of KR25102 in Healthy… Healthy Volunteers (HV) Not Yet Recruiting
Disease Areas
Get alerts when Jiangxi Kvvit Pharmaceutical Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free